These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9142299)

  • 61. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
    Langrehr JM; Neuhaus PJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
    [No Abstract]   [Full Text] [Related]  

  • 62. The US compassionate experience with thymoglobulin for the treatment of resistant acute rejection.
    Daoud AJ; Schroeder TJ; Kano J; Horn HR; Moran HB; First MR
    Transplant Proc; 1997 Nov; 29(7A):18S-20S. PubMed ID: 9366921
    [No Abstract]   [Full Text] [Related]  

  • 63. The impact of antilymphocyte therapy on sensitized patients in renal transplantation.
    Santi S; Fop F; Segoloni G; Piccoli G
    Transplant Proc; 2001; 33(1-2):1090. PubMed ID: 11267204
    [No Abstract]   [Full Text] [Related]  

  • 64. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 65. Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.
    Rahamimov R; Yussim A; After T; Lustig S; Bar-Nathan N; Shaharabani E; Shapira Z; Shabthai E; Mor E
    Transplant Proc; 2003 Mar; 35(2):653-4. PubMed ID: 12644082
    [No Abstract]   [Full Text] [Related]  

  • 66. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Study of graft-infiltrating cells in the rat small bowel allograft using low-dose FK 506.
    Azuma T; Nakai H; Okada A; Revillon Y
    Transplant Proc; 1999 Nov; 31(7):2790-1. PubMed ID: 10578293
    [No Abstract]   [Full Text] [Related]  

  • 69. Epidermal growth factor enhances the intestinal adaptation of small bowel allografts in the postoperative period.
    Kato Y; Hamada Y; Nakai K; Okumura T; Hioki K
    Transplant Proc; 2000 Sep; 32(6):1253-4. PubMed ID: 10995935
    [No Abstract]   [Full Text] [Related]  

  • 70. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome of living unrelated (commercial) renal transplantation: report of 20 cases.
    Ben Hamida F; Ben Abdallah T; Goucha R; Hedri H; Helal I; Karoui C; Abderrahim E; Ben Moussa F; Kheder A; Ben Maïz H
    Transplant Proc; 2001 Aug; 33(5):2660-1. PubMed ID: 11498111
    [No Abstract]   [Full Text] [Related]  

  • 72. Kidney transplantation in Cyprus.
    Kyriakides GK; Hadjigavriel M; Nicolaou P; Nicolaides A; Kyriakides M
    Transplant Proc; 1993 Apr; 25(2):2129-30. PubMed ID: 8470291
    [No Abstract]   [Full Text] [Related]  

  • 73. Long-term results of spousal renal donor transplants with donor-specific blood transfusions.
    Miura S; Okazaki H; Sato T; Amada N; Ohashi Y; Sato K
    Transplant Proc; 2001; 33(7-8):3417-9. PubMed ID: 11750463
    [No Abstract]   [Full Text] [Related]  

  • 74. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
    Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of acute rejection.
    Adams DH; Neuberger JM
    Semin Liver Dis; 1992 Feb; 12(1):80-8. PubMed ID: 1570553
    [No Abstract]   [Full Text] [Related]  

  • 76. Living-related small bowel transplantation for three patients with short gut syndrome.
    Li M; Ji G; Feng F; Song W; Ling R; Chen D; Liu X; Li J; Shi H; Wang W; Zhang H
    Transplant Proc; 2008 Dec; 40(10):3629-33. PubMed ID: 19100455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy.
    Norman DJ
    Semin Nephrol; 1992 Jul; 12(4):315-24. PubMed ID: 1410859
    [No Abstract]   [Full Text] [Related]  

  • 78. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 79. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
    Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B
    Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989
    [No Abstract]   [Full Text] [Related]  

  • 80. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.